BriaCell Therapeutics Cor... (BCTX)
NASDAQ: BCTX
· Real-Time Price · USD
13.08
0.25 (1.95%)
At close: Oct 03, 2025, 3:59 PM
13.10
0.14%
After-hours: Oct 03, 2025, 07:54 PM EDT
1.95% (1D)
| Bid | 12.97 |
| Market Cap | 22.96M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -19.43M |
| EPS (ttm) | -76.9 |
| PE Ratio (ttm) | -0.17 |
| Forward PE | -0.8 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 13.29 |
| Volume | 93,458 |
| Avg. Volume (20D) | 139,538 |
| Open | 12.83 |
| Previous Close | 12.83 |
| Day's Range | 12.60 - 13.50 |
| 52-Week Range | 3.50 - 98.20 |
| Beta | 1.62 |
| Ex-Dividend Date | n/a |
About BCTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BCTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BCTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+9.61%
BriaCell Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
2 months ago
-61.78%
BriaCell Therapeutics shares are trading lower after the company announced the pricing of a $15 million offering of 12 million units at $1.25 per unit.
